—Late-breaking BIOADAPTOR RCT data to highlight two-year clinical outcomes of the DynamX Bioadaptor, the first therapy designed to restore coronary artery hemodynamic modulation and improve PCI ...
Impact of Lean Body Mass–Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial The trials were conducted ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...
A head-to-head trial of minimally invasive procedures to manage benign prostatic hyperplasia found that urethral implants appear to provide more durable control of symptoms than thermal therapy. The ...
A large trial of people with earlier stages of prostate cancer compared two types of external radiation treatments head-to-head—proton beam therapy and intensity-modulated radiation therapy, or ...
Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...
A final discussion point is real-world applicability. Although PHAROS presents exceptional PFS, the modest difference between ...
Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) The trials were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback